It is an SHH-pathway inhibitor used as targeted therapy for SHH-subtype medulloblastomas. It is used commonly as combination therapy with surgery and chemotherapy for adult medulloblastomas as SHH tends to be the common type in older populations. Here, SHH is linked to medulloblastoma.